TREA

79316567 - REGULGENT

Follow

Information

  • Trademark
  • 79316567
  • Serial Number
    79316567
  • Registration Number
    6816928
  • Filing Date
    May 26, 2021
    4 years ago
  • Registration Date
    August 16, 2022
    3 years ago
  • Transaction Date
    December 21, 2022
    3 years ago
  • Status Date
    August 16, 2022
    3 years ago
  • Published for Opposition Date
    May 31, 2022
    3 years ago
  • Location Date
    August 16, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MESSICK, TABITHA LEE
  • Attorney Docket Number
    TM22-423
    Attorney Name
    Kaushal Odedra
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
REGULGENT
Case File Statements
  • GS0401: Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; Custom manufacturing, namely, contract , refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of custom manufacturing in the field of antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies and derivatives of antibodies; providing information in the field of custom manufacturing in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of pharmaceuticals comprising antibodies, fragments of antibodies and derivatives of antibodies; providing information in the field of custom manufacturing in the field of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of custom manufacturing in the field of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; providing technical information in the field of contract manufacturing that consists of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; technical consultation in the field of manufacturing that consists of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
  • GS0051: Pharmaceuticals comprising monospecific, bispecific or multispecific antibodies, fragments of monospecific, bispecific or multispecific antibodies and derivatives of monospecific, bispecific or multispecific antibodies for medical purposes; cells for medical use, namely, cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies for medical purposes; cells for medical purposes
  • GS0421: Development of antibodies, fragments of antibodies and derivatives of antibodies for others; development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies for others; development of host cells for others; providing technical information in the field of development of antibodies, fragments of antibodies and derivatives of antibodies; providing technical information in the field of development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of development of antibodies, fragments of antibodies and derivatives of antibodies; technical consultation in the field of development of cells that manufacture antibodies, fragments of antibodies and derivatives of antibodies
Case File Event Statements
  • 12/21/2022 - 3 years ago
    23 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 11/26/2022 - 3 years ago
    22 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/26/2022 - 3 years ago
    21 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/16/2022 - 3 years ago
    20 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/16/2022 - 3 years ago
    19 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/16/2022 - 3 years ago
    18 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/31/2022 - 3 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/31/2022 - 3 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/11/2022 - 3 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/26/2022 - 3 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/23/2022 - 3 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/23/2022 - 3 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/23/2022 - 3 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/11/2022 - 3 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/18/2022 - 3 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/18/2022 - 3 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/17/2022 - 4 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/16/2022 - 4 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/9/2022 - 4 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/10/2021 - 4 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/6/2021 - 4 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/5/2021 - 4 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 7/29/2021 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR